265. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter
Min, J-J, Chung JK, Lee YJ, Shin JH, Yeo JS, Jeong JM, Lee DS, Bom H-S, Lee MC
29:537-545
264. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability
Kang GH, Lee S, Shim YH, Kim JC, Ro JY
52:764-768
263. Production and characterisation of a recombinant scFv reactive with human gastrointestinal carcinomas.
Kim D-J, Chung J-H, Rye Y-S, Rhim J-H, Kim C-W, Suh Y, Chung H-K
87:405-413
262. Identification of antigenic peptide recognized by the anti-JL1 leukemia-specific monoclonal antibody from combinatorial peptide phage display libraries
Chung J, Park S, Kim D, Rhim J, Kim I, Choi I, Yi K, Rye S, Suh P, Chung D, Bae Y, Shin Y, Park S
128:641-649
261. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET
Chung J-K, Kim YK, Kim S-K, Lee YJ, Paek S, Yeo JS, Jeong JM, Lee DS, Jung HW, Lee MC
29:1767-182
260. Tumor removal enhances immunity induced by B7.1
Lee M-J, Choi S-H, Shim Y-H, Cho S-H, Kim CW
69:281-288
259. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-b1 in NCI-H929 multiple myeloma cells
Park WH, Seol JG, Kim ES, Binderup L, Koeffler HP, Kim BK, Lee YY
20:533-542
258. Synthesis of 188Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer
Lee Y-S, Jeong JM, Kim YJ, Chung JW, Park JH, Suh Y-G, Lee DS, Chung J-K, Lee MC
23:237-242
257. Suspected HNPCC and amsterdam cirtieria II: evaluation of mutation detection rate, an international collaborative study
Park J-G, Vasen HFA, Park YJ, Park KJ, Peltomaki P. Leon MP, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard M-L, Miyaki M, Wijnen JT, Baba S, Lindblom A, Madlensky L, Lynch HT
17:109-114
256. SNU cell lines and their application for cancer research